Integra LifeSciences Holdings Corporation
HealthcareNASDAQ:IART · NASDAQ Global Select
+$0.26 today
Vol 0.51M · Avg 0.96M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-49.5%
avg 0.6%
ROIC
1.9%
avg 3.0%
ROA
-14.3%
avg 0.9%
Analysis
ROIC is currently the strongest return metric at 1.9% versus its period average of 3.0%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Mojdeh Poul | President, Chief Executive Officer & Director | $1.91M | — | 63 | $445,691.00 | 0.57% |
Michael J. McBreen | Chief Commercial Officer | $942,931.00 | — | 60 | $159,911.00 | 0.21% |
Lea Daniels Knight | Executive Vice President & Chief Financial Officer | $884,701.00 | — | 54 | $111,179.00 | 0.14% |
Robert T. Davis Jr. | Executive Vice President & President of Tissue Technologies | $722,354.00 | — | 67 | $66,387.00 | 0.09% |
Harvinder Singh | Executive Vice President & President of International Business | $714,613.00 | — | 60 | $40,612.00 | 0.05% |
Michael D. Hutchinson | Executive Vice President, Chief Legal Officer & Secretary | $549,518.00 | — | 55 | $159,911.00 | 0.21% |
Jeffrey Mosebrook | Senior Vice President of Finance & Principal Accounting Officer | $493,138.00 | — | 50 | $17,700.00 | 0.02% |
Stuart Essig | CEO, President & Chairman | $85,000.00 | — | 64 | $200,000.00 | 0.26% |
Christopher Ward | Senior Director of Investor Relations | — | — | — | — | — |
Laurene Isip | Vice President of Global Corporate Communications & Public Relations | — | — | — | — | — |
Teshtar Elavia | Corporate VP & Chief Technology Officer | — | — | — | — | — |
Chantal Veillon-Berteloot | Executive Vice President & Chief Human Resources Officer | — | — | 55 | $41,783.00 | 0.05% |
Jessica Smith | Corporate VP & Global Quality and Chief Regulatory Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
1
$102,150.00
Sells
0
$0.00
Net Sentiment
+$102,150.00
Net buying
Most Active
GRAVES JEFFREY A
1 transactions
Analysis
Insiders reported 1 buys worth $102,150.00 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $102,150.00. GRAVES JEFFREY A was the most active insider with 1 transactions.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | +2.0% | +5.6% (13yr)6 analysts |
| Net Income | N/A | N/A | N/A | N/A6 analysts |
| EBIT | N/A | N/A | +2.6% | -2.8% (13yr)6 analysts |
Analysis
Recent growth has been strongest in EBIT at +2.6% over three years. Forward estimates point to Revenue at +5.6% (13yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Peer companies in the same sector
Septerna, Inc.
NASDAQ:SEPN
$1.62B
Fortrea Holdings Inc.
NASDAQ:FTRE
$1.56B
Butterfly Network, Inc.
NYSE:BFLY
$1.45B
Bicara Therapeutics Inc. Common Stock
NASDAQ:BCAX
$1.19B
Tandem Diabetes Care, Inc.
NASDAQ:TNDM
$1.14B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.09B
InMode Ltd.
NASDAQ:INMD
$817.88M
Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
$722.58M
Myriad Genetics, Inc.
NASDAQ:MYGN
$408.96M
Pacific Biosciences of California, Inc.
NASDAQ:PACB
$406.89M
Who manages IART?
Integra LifeSciences Holdings Corporation (IART) lists 13 active executives. The top listed executive is Harvinder Singh, Executive Vice President & President of International Business.
Are IART insiders buying or selling?
Recent insider activity shows net buying of $16.25M.
Explore More
Continue the stock analysis
Jump to another research area for this company.